Darolutamide in the Treatment of Non-Metastatic Castration Resistant Prostate Cancer (nmCRPC)

In an effort to promote higher quality patient care the NCODA created the NCODA Positive Quality Intervention (PQI) as a peer-reviewed clinical guidance document for healthcare providers. By providing Quality Standards and effective practices around a specific aspect of cancer care, PQIs equip the entire multidisciplinary care team with a sophisticated yet concise resource for managing patients receiving oral or IV oncolytics. This PQI in Action is a follow up to the Nubeqa (darolutamide) PQI and explores how the medically integrated teams at Florida Cancer Specialists and Regional Cancer Care Associates – Central Jersey Division incorporate PQI’s as part of their daily workflow. It will discuss how utilizing the Darolutamide in the treatment of non-metastatic castration resistant prostate cancer (nmCRPC) PQI elevates patient care.